1h Free Analyst Time
The widespread adoption of contact lenses as a preferred alternative to spectacles has ushered in significant benefits in vision correction, aesthetics, and user convenience. However, alongside this growth has come a parallel rise in contact-lens induced infections, driven by lapses in hygiene, evolving lens materials, and complex supply chains. This executive summary explores the multifaceted challenges posed by microbial keratitis, conjunctivitis, and other ocular complications, providing a comprehensive foundation for understanding risk factors, industry responses, and strategic imperatives. By synthesizing key trends, tariff impacts, segmentation dynamics, regional variations, and competitive movements, this introduction sets the stage for actionable insights that enable manufacturers, clinicians, and policymakers to elevate safety standards, optimize product development, and enhance patient outcomes.Speak directly to the analyst to clarify any post sales queries you may have.
Transformative Shifts Reshaping the Infection Landscape
Over the past decade, the contact lens market has experienced transformative shifts that directly influence infection risk and mitigation strategies. Breakthroughs in silicone hydrogel and hybrid materials have improved oxygen permeability but require rigorous care protocols to prevent biofilm formation. Disinfection systems fortified with hydrogen peroxide and novel chemical solutions are gaining traction as daily wear and overnight wear modalities expand. Digital health and telemedicine have emerged as critical conduits for patient education, enabling real-time monitoring of lens compliance levels and maintenance habits. Concurrently, regulatory frameworks are adapting to encompass advanced lens-care formulations and enforce stricter quality standards across import and distribution channels. As consumer awareness of ocular health deepens, long-term users and first-time users alike demand transparent guidance on lens usage motivation and allergic reactions. The convergence of these technological, regulatory, and behavioral dynamics is reshaping industry priorities, driving stakeholders to adopt integrated risk-management models that balance innovation with uncompromised hygiene.Cumulative Impact of United States Tariffs in 2025 on the Infection Market
The implementation of new tariffs in 2025 has reverberated across the contact-lens infection landscape, altering raw material costs, import strategies, and downstream pricing structures. Suppliers reliant on cross-border shipments of hydrogel components and chemical disinfectants face increased cost pressures that may prompt consolidation among distributors. In response, some manufacturers are localizing production to mitigate tariff-induced volatility, while others are adjusting supply-chain partnerships to ensure uninterrupted access to silicone hydrogel and hybrid materials. These adjustments, though necessary for cost containment, risk introducing variability in product quality and compliance standards-factors that could inadvertently elevate bacterial, fungal, or parasitic infection rates. Health-care providers are likewise recalibrating procurement policies, balancing budgetary constraints against the imperative of maintaining approved keratitis-preventive lenses. Ultimately, the cumulative impact of these tariffs underscores the need for robust collaboration between policymakers, manufacturers, and clinicians to safeguard patient outcomes without undermining market stability.Key Segmentation Insights Driving Market Differentiation
Segmentation by age group reveals distinct susceptibility and compliance patterns: children and infants often rely on caregiver support for proper maintenance, teenagers exhibit fluctuating habits that increase risk, adults demonstrate higher adherence but may juggle cosmetic usage with refractive correction, while elderly patients contend with comorbid eye disorders such as astigmatism or hyperopia; middle aged individuals spanning 40-50 and 50-60 engage with a spectrum of daily wear and extended wear options tailored to lifestyle demands. Lens type segmentation underscores material performance: rigid gas permeable and scleral lenses offer robustness but demand meticulous care, hybrid lenses blend durability with comfort, and soft lenses-available in daily wear and extended wear formats-dominate usage yet require consistent disinfection to prevent conjunctivitis or keratitis. When classified by infection type, bacterial infections subtyped into conjunctivitis and keratitis account for the majority of clinical cases, while fungal, parasitic, and viral infections represent emerging concerns in immunocompromised and high-incidence regions. Material type segmentation further distinguishes hybrid materials from hydrogel and silicone hydrogel, each presenting unique oxygen transmission and moisture retention profiles with implications for biofilm resistance. Wear duration-from daily through fortnightly and monthly to overnight use-affects microbial proliferation on lens surfaces, with improper maintenance habits magnifying risk. Patient compliance levels span high, medium, and low tiers, influencing incidence rates in tandem with care routines involving chemical versus hydrogen peroxide solutions. User experience differentiates first-time, regular, and long-term users, the latter subdivided into those with over three years and above five years of lens wear, while availability of treatment options divides accessible eye care services from limited access settings. Allergic reaction incidence-high, moderate, or low-intersects with lens usage motivation, whether cosmetic or corrective, to shape personalized risk profiles. Collectively, these segmentation insights illuminate tailored intervention points for product innovation, education campaigns, and regulatory oversight.Key Regional Insights Highlighting Global Variations
In the Americas, robust health-care infrastructure and high patient compliance levels support widespread adoption of advanced silicones and peroxide-based disinfection systems, yet pockets of limited access to eye care services persist in rural areas. Within Europe, Middle East & Africa, regulatory harmonization efforts are accelerating, and adoption of hybrid and rigid gas permeable lenses is on the rise; however, varying allergic reaction incidence rates across climatic zones and disparities in hydrogen peroxide solution availability underscore region-specific challenges. Asia-Pacific markets exhibit rapid growth in daily wear soft lenses driven by cosmetic usage, balanced by concerns around medium to low compliance levels and inconsistent lens care education; simultaneously, burgeoning urban centers are investing in telehealth platforms that enhance monitoring of keratitis risk among first-time and long-term users. These regional dynamics highlight the importance of calibrating product portfolios, distribution models, and patient outreach to local epidemiology and infrastructural realities.Key Company Insights Shaping Competitive Dynamics
Leading stakeholders are differentiating through targeted research, strategic partnerships, and product diversification. Abbott Medical Optics Inc. emphasizes antimicrobial coatings to deter microbial colonization on lens surfaces, while Alcon Vision LLC advances daily wear silicone hydrogel innovations that enhance oxygen transmission and wearer comfort. Bausch & Lomb Incorporated and Johnson & Johnson Vision Care, Inc. integrate telehealth diagnostics into routine eye examinations, leveraging data analytics to preempt infection onset. Carl Zeiss AG extends its diagnostic portfolio with high-resolution imaging to detect early signs of keratitis. Conforma Contact Lenses Ltd. and Menicon Co., Ltd. specialize in custom lens geometries optimized for scleral and rigid gas permeable applications. CooperVision, Inc. and The Cooper Companies, Inc. broaden their soft lens assortments with extended wear and cosmetic tinted options, while EssilorLuxottica and HOYA Corporation collaborate on preservative-free solutions that address allergic reaction incidence. Lions Eye Institute Ltd. and Scotlens Ltd. focus on niche patient segments with high compliance demands, and SynergEyes, Inc. innovates hybrid designs that combine gas permeability with soft lens comfort. Visioneering Technologies, Inc. rounds out the competitive landscape by developing smart lens technologies that monitor ocular parameters in real time. Together, these companies are redefining best practices across materials, design, diagnostics, and care delivery.Actionable Recommendations for Industry Leaders
Industry leaders should prioritize multifaceted strategies to elevate safety and market resilience. First, invest in research and development of antimicrobial and preservative-free lens care formulations to mitigate bacterial and fungal colonization. Second, enhance patient education programs that reinforce proper maintenance habits, leveraging digital platforms to deliver personalized compliance nudges. Third, diversify supply chains and localize production to absorb tariff shocks while maintaining stringent quality controls. Fourth, partner with eye-care providers to integrate telemedicine solutions that enable early detection of parasitic and viral infections. Fifth, collaborate with regulatory bodies to streamline approval pathways for innovative materials and disinfectants. Lastly, segment outreach by demographic, usage motivation, and regional profiles to tailor marketing and training initiatives, ensuring that interventions resonate with first-time users, long-term wearers, and underserved populations alike.Conclusion: Navigating the Future of Safe Contact-Lens Use
The evolving landscape of contact-lens induced infections demands a cohesive response rooted in innovation, collaboration, and patient-centricity. By aligning advanced material science with rigorous disinfection protocols, industry stakeholders can curtail infection incidence without compromising user convenience. Regional and demographic variations necessitate adaptive strategies that reflect local health-care infrastructures, compliance behaviors, and regulatory environments. Competitive dynamics will hinge on the ability to integrate real-time diagnostics, support high compliance levels, and anticipate emerging threats such as fungal and viral pathogens. As market players, clinicians, and policymakers unite around shared objectives, the path forward will be defined by data-driven insights, agile decision-making, and a steadfast commitment to ocular safety.Market Segmentation & Coverage
This research report categorizes the Contact-lens Induced Infection Market to forecast the revenues and analyze trends in each of the following sub-segmentations:
- Adults
- Children
- Elderly
- Infants
- Middle Aged Individuals
- Aged 40-50
- Aged 50-60
- Teenagers
- Hybrid Lenses
- Rigid Gas Permeable Lenses
- Scleral Lenses
- Soft Lenses
- Daily Wear
- Extended Wear
- Bacterial Infections
- Conjunctivitis
- Keratitis
- Fungal Infections
- Parasitic Infections
- Viral Infections
- Hybrid Materials
- Hydrogel
- Silicone Hydrogel
- Daily Wear
- Fortnightly Wear
- Monthly Wear
- Overnight Wear
- High Compliance
- Low Compliance
- Medium Compliance
- Improper Maintenance
- Proper Maintenance
- Use of Chemical Solutions
- Use of Hydrogen Peroxide Solutions
- First-Time Users
- Long-Term Users
- Users Above 5 Years
- Users Over 3 Years
- Regular Users
- Accessible Eye Care Services
- Limited Access to Eye Care
- High Incidence
- Low Incidence
- Moderate Incidence
- Cosmetic Usage
- Refractive Correction
- Astigmatism
- Hyperopia
- Myopia
This research report categorizes the Contact-lens Induced Infection Market to forecast the revenues and analyze trends in each of the following sub-regions:
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
This research report categorizes the Contact-lens Induced Infection Market to delves into recent significant developments and analyze trends in each of the following companies:
- Abbott Medical Optics Inc.
- Alcon Vision LLC
- Bausch & Lomb Incorporated
- Carl Zeiss AG
- Conforma Contact Lenses Ltd.
- CooperVision, Inc.
- EssilorLuxottica
- HOYA Corporation
- Johnson & Johnson Vision Care, Inc.
- Lions Eye Institute Ltd.
- Menicon Co., Ltd.
- Scotlens Ltd.
- SynergEyes, Inc.
- The Cooper Companies, Inc.
- Visioneering Technologies, Inc.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Contact-lens Induced Infection Market, by Age Group
8.1. Introduction
8.2. Adults
8.3. Children
8.4. Elderly
8.5. Infants
8.6. Middle Aged Individuals
8.6.1. Aged 40-50
8.6.2. Aged 50-60
8.7. Teenagers
9. Contact-lens Induced Infection Market, by Type of Contact Lenses
9.1. Introduction
9.2. Hybrid Lenses
9.3. Rigid Gas Permeable Lenses
9.4. Scleral Lenses
9.5. Soft Lenses
9.5.1. Daily Wear
9.5.2. Extended Wear
10. Contact-lens Induced Infection Market, by Type of Infection
10.1. Introduction
10.2. Bacterial Infections
10.2.1. Conjunctivitis
10.2.2. Keratitis
10.3. Fungal Infections
10.4. Parasitic Infections
10.5. Viral Infections
11. Contact-lens Induced Infection Market, by Material Type
11.1. Introduction
11.2. Hybrid Materials
11.3. Hydrogel
11.4. Silicone Hydrogel
12. Contact-lens Induced Infection Market, by Wear Duration
12.1. Introduction
12.2. Daily Wear
12.3. Fortnightly Wear
12.4. Monthly Wear
12.5. Overnight Wear
13. Contact-lens Induced Infection Market, by Patient Compliance Level
13.1. Introduction
13.2. High Compliance
13.3. Low Compliance
13.4. Medium Compliance
14. Contact-lens Induced Infection Market, by Lens Care and Maintenance Habits
14.1. Introduction
14.2. Improper Maintenance
14.3. Proper Maintenance
14.4. Use of Chemical Solutions
14.5. Use of Hydrogen Peroxide Solutions
15. Contact-lens Induced Infection Market, by User Experience
15.1. Introduction
15.2. First-Time Users
15.3. Long-Term Users
15.3.1. Users Above 5 Years
15.3.2. Users Over 3 Years
15.4. Regular Users
16. Contact-lens Induced Infection Market, by Availability of Treatment Options
16.1. Introduction
16.2. Accessible Eye Care Services
16.3. Limited Access to Eye Care
17. Contact-lens Induced Infection Market, by Allergic Reaction Incidence
17.1. Introduction
17.2. High Incidence
17.3. Low Incidence
17.4. Moderate Incidence
18. Contact-lens Induced Infection Market, by Lens Usage Motivation
18.1. Introduction
18.2. Cosmetic Usage
18.3. Refractive Correction
19. Contact-lens Induced Infection Market, by Presence of Eye Disorders
19.1. Introduction
19.2. Astigmatism
19.3. Hyperopia
19.4. Myopia
20. Americas Contact-lens Induced Infection Market
20.1. Introduction
20.2. Argentina
20.3. Brazil
20.4. Canada
20.5. Mexico
20.6. United States
21. Asia-Pacific Contact-lens Induced Infection Market
21.1. Introduction
21.2. Australia
21.3. China
21.4. India
21.5. Indonesia
21.6. Japan
21.7. Malaysia
21.8. Philippines
21.9. Singapore
21.10. South Korea
21.11. Taiwan
21.12. Thailand
21.13. Vietnam
22. Europe, Middle East & Africa Contact-lens Induced Infection Market
22.1. Introduction
22.2. Denmark
22.3. Egypt
22.4. Finland
22.5. France
22.6. Germany
22.7. Israel
22.8. Italy
22.9. Netherlands
22.10. Nigeria
22.11. Norway
22.12. Poland
22.13. Qatar
22.14. Russia
22.15. Saudi Arabia
22.16. South Africa
22.17. Spain
22.18. Sweden
22.19. Switzerland
22.20. Turkey
22.21. United Arab Emirates
22.22. United Kingdom
23. Competitive Landscape
23.1. Market Share Analysis, 2024
23.2. FPNV Positioning Matrix, 2024
23.3. Competitive Analysis
23.3.1. Abbott Medical Optics Inc.
23.3.2. Alcon Vision LLC
23.3.3. Bausch & Lomb Incorporated
23.3.4. Carl Zeiss AG
23.3.5. Conforma Contact Lenses Ltd.
23.3.6. CooperVision, Inc.
23.3.7. EssilorLuxottica
23.3.8. HOYA Corporation
23.3.9. Johnson & Johnson Vision Care, Inc.
23.3.10. Lions Eye Institute Ltd.
23.3.11. Menicon Co., Ltd.
23.3.12. Scotlens Ltd.
23.3.13. SynergEyes, Inc.
23.3.14. The Cooper Companies, Inc.
23.3.15. Visioneering Technologies, Inc.
24. ResearchAI
25. ResearchStatistics
26. ResearchContacts
27. ResearchArticles
28. Appendix
List of Figures
FIGURE 1. CONTACT-LENS INDUCED INFECTION MARKET MULTI-CURRENCY
FIGURE 2. CONTACT-LENS INDUCED INFECTION MARKET MULTI-LANGUAGE
FIGURE 3. CONTACT-LENS INDUCED INFECTION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF CONTACT LENSES, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF CONTACT LENSES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF INFECTION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF INFECTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY WEAR DURATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY WEAR DURATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS CARE AND MAINTENANCE HABITS, 2024 VS 2030 (%)
FIGURE 20. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS CARE AND MAINTENANCE HABITS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY USER EXPERIENCE, 2024 VS 2030 (%)
FIGURE 22. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY USER EXPERIENCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AVAILABILITY OF TREATMENT OPTIONS, 2024 VS 2030 (%)
FIGURE 24. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AVAILABILITY OF TREATMENT OPTIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY ALLERGIC REACTION INCIDENCE, 2024 VS 2030 (%)
FIGURE 26. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY ALLERGIC REACTION INCIDENCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS USAGE MOTIVATION, 2024 VS 2030 (%)
FIGURE 28. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS USAGE MOTIVATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PRESENCE OF EYE DISORDERS, 2024 VS 2030 (%)
FIGURE 30. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PRESENCE OF EYE DISORDERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. AMERICAS CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 32. AMERICAS CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. UNITED STATES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 34. UNITED STATES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 35. ASIA-PACIFIC CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 36. ASIA-PACIFIC CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 37. EUROPE, MIDDLE EAST & AFRICA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 38. EUROPE, MIDDLE EAST & AFRICA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 39. CONTACT-LENS INDUCED INFECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 40. CONTACT-LENS INDUCED INFECTION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CONTACT-LENS INDUCED INFECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MIDDLE AGED INDIVIDUALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AGED 40-50, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AGED 50-60, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MIDDLE AGED INDIVIDUALS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TEENAGERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF CONTACT LENSES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY HYBRID LENSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY RIGID GAS PERMEABLE LENSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY SCLERAL LENSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY SOFT LENSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY DAILY WEAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY EXTENDED WEAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY SOFT LENSES, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF INFECTION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY CONJUNCTIVITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY KERATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY FUNGAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY HYBRID MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY HYDROGEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY SILICONE HYDROGEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY WEAR DURATION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY DAILY WEAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY FORTNIGHTLY WEAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MONTHLY WEAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY OVERNIGHT WEAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY HIGH COMPLIANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LOW COMPLIANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MEDIUM COMPLIANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS CARE AND MAINTENANCE HABITS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY IMPROPER MAINTENANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PROPER MAINTENANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY USE OF CHEMICAL SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY USE OF HYDROGEN PEROXIDE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY FIRST-TIME USERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LONG-TERM USERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY USERS ABOVE 5 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY USERS OVER 3 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LONG-TERM USERS, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY REGULAR USERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AVAILABILITY OF TREATMENT OPTIONS, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY ACCESSIBLE EYE CARE SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LIMITED ACCESS TO EYE CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY ALLERGIC REACTION INCIDENCE, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY HIGH INCIDENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LOW INCIDENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MODERATE INCIDENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS USAGE MOTIVATION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY COSMETIC USAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY REFRACTIVE CORRECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PRESENCE OF EYE DISORDERS, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY ASTIGMATISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY HYPEROPIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MYOPIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MIDDLE AGED INDIVIDUALS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF CONTACT LENSES, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY SOFT LENSES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF INFECTION, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY WEAR DURATION, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS CARE AND MAINTENANCE HABITS, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LONG-TERM USERS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AVAILABILITY OF TREATMENT OPTIONS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY ALLERGIC REACTION INCIDENCE, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS USAGE MOTIVATION, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PRESENCE OF EYE DISORDERS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MIDDLE AGED INDIVIDUALS, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF CONTACT LENSES, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY SOFT LENSES, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF INFECTION, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY WEAR DURATION, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS CARE AND MAINTENANCE HABITS, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LONG-TERM USERS, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AVAILABILITY OF TREATMENT OPTIONS, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY ALLERGIC REACTION INCIDENCE, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS USAGE MOTIVATION, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PRESENCE OF EYE DISORDERS, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MIDDLE AGED INDIVIDUALS, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF CONTACT LENSES, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY SOFT LENSES, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF INFECTION, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY WEAR DURATION, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS CARE AND MAINTENANCE HABITS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LONG-TERM USERS, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AVAILABILITY OF TREATMENT OPTIONS, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY ALLERGIC REACTION INCIDENCE, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS USAGE MOTIVATION, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PRESENCE OF EYE DISORDERS, 2018-2030 (USD MILLION)
TABLE 120. CANADA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 121. CANADA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MIDDLE AGED INDIVIDUALS, 2018-2030 (USD MILLION)
TABLE 122. CANADA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF CONTACT LENSES, 2018-2030 (USD MILLION)
TABLE 123. CANADA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY SOFT LENSES, 2018-2030 (USD MILLION)
TABLE 124. CANADA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF INFECTION, 2018-2030 (USD MILLION)
TABLE 125. CANADA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 126. CANADA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 127. CANADA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY WEAR DURATION, 2018-2030 (USD MILLION)
TABLE 128. CANADA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 129. CANADA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS CARE AND MAINTENANCE HABITS, 2018-2030 (USD MILLION)
TABLE 130. CANADA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 131. CANADA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LONG-TERM USERS, 2018-2030 (USD MILLION)
TABLE 132. CANADA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AVAILABILITY OF TREATMENT OPTIONS, 2018-2030 (USD MILLION)
TABLE 133. CANADA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY ALLERGIC REACTION INCIDENCE, 2018-2030 (USD MILLION)
TABLE 134. CANADA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS USAGE MOTIVATION, 2018-2030 (USD MILLION)
TABLE 135. CANADA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PRESENCE OF EYE DISORDERS, 2018-2030 (USD MILLION)
TABLE 136. MEXICO CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 137. MEXICO CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MIDDLE AGED INDIVIDUALS, 2018-2030 (USD MILLION)
TABLE 138. MEXICO CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF CONTACT LENSES, 2018-2030 (USD MILLION)
TABLE 139. MEXICO CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY SOFT LENSES, 2018-2030 (USD MILLION)
TABLE 140. MEXICO CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF INFECTION, 2018-2030 (USD MILLION)
TABLE 141. MEXICO CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 142. MEXICO CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 143. MEXICO CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY WEAR DURATION, 2018-2030 (USD MILLION)
TABLE 144. MEXICO CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 145. MEXICO CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS CARE AND MAINTENANCE HABITS, 2018-2030 (USD MILLION)
TABLE 146. MEXICO CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 147. MEXICO CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LONG-TERM USERS, 2018-2030 (USD MILLION)
TABLE 148. MEXICO CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AVAILABILITY OF TREATMENT OPTIONS, 2018-2030 (USD MILLION)
TABLE 149. MEXICO CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY ALLERGIC REACTION INCIDENCE, 2018-2030 (USD MILLION)
TABLE 150. MEXICO CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS USAGE MOTIVATION, 2018-2030 (USD MILLION)
TABLE 151. MEXICO CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PRESENCE OF EYE DISORDERS, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MIDDLE AGED INDIVIDUALS, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF CONTACT LENSES, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY SOFT LENSES, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF INFECTION, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY WEAR DURATION, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS CARE AND MAINTENANCE HABITS, 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LONG-TERM USERS, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AVAILABILITY OF TREATMENT OPTIONS, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY ALLERGIC REACTION INCIDENCE, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS USAGE MOTIVATION, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PRESENCE OF EYE DISORDERS, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MIDDLE AGED INDIVIDUALS, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF CONTACT LENSES, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY SOFT LENSES, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF INFECTION, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 176. ASIA-PACIFIC CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY WEAR DURATION, 2018-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 178. ASIA-PACIFIC CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS CARE AND MAINTENANCE HABITS, 2018-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 180. ASIA-PACIFIC CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LONG-TERM USERS, 2018-2030 (USD MILLION)
TABLE 181. ASIA-PACIFIC CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AVAILABILITY OF TREATMENT OPTIONS, 2018-2030 (USD MILLION)
TABLE 182. ASIA-PACIFIC CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY ALLERGIC REACTION INCIDENCE, 2018-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS USAGE MOTIVATION, 2018-2030 (USD MILLION)
TABLE 184. ASIA-PACIFIC CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PRESENCE OF EYE DISORDERS, 2018-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 186. AUSTRALIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 187. AUSTRALIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MIDDLE AGED INDIVIDUALS, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF CONTACT LENSES, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY SOFT LENSES, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF INFECTION, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY WEAR DURATION, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 195. AUSTRALIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS CARE AND MAINTENANCE HABITS, 2018-2030 (USD MILLION)
TABLE 196. AUSTRALIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 197. AUSTRALIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LONG-TERM USERS, 2018-2030 (USD MILLION)
TABLE 198. AUSTRALIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AVAILABILITY OF TREATMENT OPTIONS, 2018-2030 (USD MILLION)
TABLE 199. AUSTRALIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY ALLERGIC REACTION INCIDENCE, 2018-2030 (USD MILLION)
TABLE 200. AUSTRALIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS USAGE MOTIVATION, 2018-2030 (USD MILLION)
TABLE 201. AUSTRALIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PRESENCE OF EYE DISORDERS, 2018-2030 (USD MILLION)
TABLE 202. CHINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 203. CHINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MIDDLE AGED INDIVIDUALS, 2018-2030 (USD MILLION)
TABLE 204. CHINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF CONTACT LENSES, 2018-2030 (USD MILLION)
TABLE 205. CHINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY SOFT LENSES, 2018-2030 (USD MILLION)
TABLE 206. CHINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF INFECTION, 2018-2030 (USD MILLION)
TABLE 207. CHINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 208. CHINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 209. CHINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY WEAR DURATION, 2018-2030 (USD MILLION)
TABLE 210. CHINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 211. CHINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS CARE AND MAINTENANCE HABITS, 2018-2030 (USD MILLION)
TABLE 212. CHINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 213. CHINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LONG-TERM USERS, 2018-2030 (USD MILLION)
TABLE 214. CHINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AVAILABILITY OF TREATMENT OPTIONS, 2018-2030 (USD MILLION)
TABLE 215. CHINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY ALLERGIC REACTION INCIDENCE, 2018-2030 (USD MILLION)
TABLE 216. CHINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS USAGE MOTIVATION, 2018-2030 (USD MILLION)
TABLE 217. CHINA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PRESENCE OF EYE DISORDERS, 2018-2030 (USD MILLION)
TABLE 218. INDIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 219. INDIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MIDDLE AGED INDIVIDUALS, 2018-2030 (USD MILLION)
TABLE 220. INDIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF CONTACT LENSES, 2018-2030 (USD MILLION)
TABLE 221. INDIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY SOFT LENSES, 2018-2030 (USD MILLION)
TABLE 222. INDIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF INFECTION, 2018-2030 (USD MILLION)
TABLE 223. INDIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 224. INDIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 225. INDIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY WEAR DURATION, 2018-2030 (USD MILLION)
TABLE 226. INDIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 227. INDIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS CARE AND MAINTENANCE HABITS, 2018-2030 (USD MILLION)
TABLE 228. INDIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 229. INDIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LONG-TERM USERS, 2018-2030 (USD MILLION)
TABLE 230. INDIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AVAILABILITY OF TREATMENT OPTIONS, 2018-2030 (USD MILLION)
TABLE 231. INDIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY ALLERGIC REACTION INCIDENCE, 2018-2030 (USD MILLION)
TABLE 232. INDIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS USAGE MOTIVATION, 2018-2030 (USD MILLION)
TABLE 233. INDIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PRESENCE OF EYE DISORDERS, 2018-2030 (USD MILLION)
TABLE 234. INDONESIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 235. INDONESIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MIDDLE AGED INDIVIDUALS, 2018-2030 (USD MILLION)
TABLE 236. INDONESIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF CONTACT LENSES, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY SOFT LENSES, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF INFECTION, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY WEAR DURATION, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS CARE AND MAINTENANCE HABITS, 2018-2030 (USD MILLION)
TABLE 244. INDONESIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 245. INDONESIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LONG-TERM USERS, 2018-2030 (USD MILLION)
TABLE 246. INDONESIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AVAILABILITY OF TREATMENT OPTIONS, 2018-2030 (USD MILLION)
TABLE 247. INDONESIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY ALLERGIC REACTION INCIDENCE, 2018-2030 (USD MILLION)
TABLE 248. INDONESIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS USAGE MOTIVATION, 2018-2030 (USD MILLION)
TABLE 249. INDONESIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PRESENCE OF EYE DISORDERS, 2018-2030 (USD MILLION)
TABLE 250. JAPAN CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 251. JAPAN CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MIDDLE AGED INDIVIDUALS, 2018-2030 (USD MILLION)
TABLE 252. JAPAN CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF CONTACT LENSES, 2018-2030 (USD MILLION)
TABLE 253. JAPAN CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY SOFT LENSES, 2018-2030 (USD MILLION)
TABLE 254. JAPAN CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF INFECTION, 2018-2030 (USD MILLION)
TABLE 255. JAPAN CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 256. JAPAN CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 257. JAPAN CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY WEAR DURATION, 2018-2030 (USD MILLION)
TABLE 258. JAPAN CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 259. JAPAN CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS CARE AND MAINTENANCE HABITS, 2018-2030 (USD MILLION)
TABLE 260. JAPAN CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 261. JAPAN CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LONG-TERM USERS, 2018-2030 (USD MILLION)
TABLE 262. JAPAN CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AVAILABILITY OF TREATMENT OPTIONS, 2018-2030 (USD MILLION)
TABLE 263. JAPAN CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY ALLERGIC REACTION INCIDENCE, 2018-2030 (USD MILLION)
TABLE 264. JAPAN CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS USAGE MOTIVATION, 2018-2030 (USD MILLION)
TABLE 265. JAPAN CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PRESENCE OF EYE DISORDERS, 2018-2030 (USD MILLION)
TABLE 266. MALAYSIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 267. MALAYSIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MIDDLE AGED INDIVIDUALS, 2018-2030 (USD MILLION)
TABLE 268. MALAYSIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF CONTACT LENSES, 2018-2030 (USD MILLION)
TABLE 269. MALAYSIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY SOFT LENSES, 2018-2030 (USD MILLION)
TABLE 270. MALAYSIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF INFECTION, 2018-2030 (USD MILLION)
TABLE 271. MALAYSIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 272. MALAYSIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 273. MALAYSIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY WEAR DURATION, 2018-2030 (USD MILLION)
TABLE 274. MALAYSIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 275. MALAYSIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS CARE AND MAINTENANCE HABITS, 2018-2030 (USD MILLION)
TABLE 276. MALAYSIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY USER EXPERIENCE, 2018-2030 (USD MILLION)
TABLE 277. MALAYSIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LONG-TERM USERS, 2018-2030 (USD MILLION)
TABLE 278. MALAYSIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AVAILABILITY OF TREATMENT OPTIONS, 2018-2030 (USD MILLION)
TABLE 279. MALAYSIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY ALLERGIC REACTION INCIDENCE, 2018-2030 (USD MILLION)
TABLE 280. MALAYSIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS USAGE MOTIVATION, 2018-2030 (USD MILLION)
TABLE 281. MALAYSIA CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PRESENCE OF EYE DISORDERS, 2018-2030 (USD MILLION)
TABLE 282. PHILIPPINES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 283. PHILIPPINES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MIDDLE AGED INDIVIDUALS, 2018-2030 (USD MILLION)
TABLE 284. PHILIPPINES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF CONTACT LENSES, 2018-2030 (USD MILLION)
TABLE 285. PHILIPPINES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY SOFT LENSES, 2018-2030 (USD MILLION)
TABLE 286. PHILIPPINES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY TYPE OF INFECTION, 2018-2030 (USD MILLION)
TABLE 287. PHILIPPINES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
TABLE 288. PHILIPPINES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 289. PHILIPPINES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY WEAR DURATION, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES CONTACT-LENS INDUCED INFECTION MARKET SIZE, BY LENS CARE AND MAINTENANCE HABITS, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES CONTACT-LENS INDUC
Companies Mentioned
- Abbott Medical Optics Inc.
- Alcon Vision LLC
- Bausch & Lomb Incorporated
- Carl Zeiss AG
- Conforma Contact Lenses Ltd.
- CooperVision, Inc.
- EssilorLuxottica
- HOYA Corporation
- Johnson & Johnson Vision Care, Inc.
- Lions Eye Institute Ltd.
- Menicon Co., Ltd.
- Scotlens Ltd.
- SynergEyes, Inc.
- The Cooper Companies, Inc.
- Visioneering Technologies, Inc.
Methodology
LOADING...
